| Mrs Linda Ann Lynch, RN, LADC 1 | |
|
2257 Main St, Springfield, MA 01107-1905 | |
| (413) 733-3488 | |
| (413) 731-7381 |
| Full Name | Mrs Linda Ann Lynch |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 2257 Main St, Springfield, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003032582 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 906 (Massachusetts) | Primary |
| 163W00000X | Registered Nurse | 110571 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Linda Ann Lynch, RN, LADC 1 833 Federal St, Belchertown, MA 01007-9373 Ph: (413) 259-1085 | Mrs Linda Ann Lynch, RN, LADC 1 2257 Main St, Springfield, MA 01107-1905 Ph: (413) 733-3488 |
News Archive
"Providing all Americans with health care coverage is crucial for the country. Health plans support legislative changes that would provide guaranteed access to all Americans, with no pre-existing condition limitations and no health-status-based premiums. These reforms are essential to giving all Americans greater peace of mind and health security.
A math professor at the University of Michigan will lead an international, $1 million project examining the links between bipolar disorder and abnormalities in the circadian, or daily, rhythms of a mammal's internal clock.
Massachusetts General Hospital (MGH) researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid (CSF) of patients with brain tumors. In their report being published in the open-access journal Molecular Therapy - Nucleic Acids, the investigators describe using advanced forms of the gene-amplification technology polymerase chain reaction (PCR) to analyze bits of RNA carried in membrane-covered sacs called extracellular vesicles for the presence of a tumor-associated mutation in a gene called IDH1.
Mazor Robotics Ltd., a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor.
Changes in blood platelets triggered by COVID-19 could contribute to the onset of heart attacks, strokes, and other serious complications in some patients who have the disease, according to University of Utah Health scientists.
› Verified 1 days ago